Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON

I Leader della Finanza

Ultime notizieSocietÓMercatiEconomia & ForexMaterie PrimeTassiLeader della FinanzaPro. della FinanzaAgendaSettori 
HomeTutte le notizieLe notizie pi¨ letteBiografie dei Leader della finanza
Portrait de David M. Tanen
EtÓ : 48
Patrimonio pubblico : 19 106 784 USD
Principali societÓ : Kronos Bio, Inc. - Allogene Therapeutics, Inc.
Riassunto 
Founder of 6 different companies, including: Kite Pharma, Inc., Allogene Therapeutics, Inc. and Arno Therapeutics, Inc. David M. Tanen is an entrepreneur and currently holds the position of Director, Vice President & Managing Member at Two River Group Management LLC, Partner at Two River Group Holdings LLC (which he founded in 2011), Director & Senior Managing Director at Riverbank Capital Securities, Inc. (a subsidiary of Two River Group Holdings LLC), Secretary at Allogene Therapeutics, Inc. (which he founded in 2007) and Secretary & Director at Neogene Therapeutics, Inc.

He is also on the board of Danube Pharmaceuticals, Inc. and Kronos Bio, Inc. and Director & Senior Managing Director at Riverbank Capital Securities, Inc., Managing Member at Two Rivers Consulting Corp. and Partner at Two River Consulting LLC (he founded the company).

Mr. Tanen previously was Secretary & Director at Arno Therapeutics, Inc. (he founded the company in 2000) and Secretary for Arno Therapeutics, Inc. (a subsidiary of Arno Therapeutics, Inc.), Secretary at Capricor Therapeutics, Inc. and Secretary at Nile Therapeutics, Inc. (a subsidiary of Capricor Therapeutics, Inc.), General Partner of Orion Biomedical Fund LP and Secretary & General Counsel for Kite Pharma, Inc. (he founded the company).

Mr. Tanen received an undergraduate degree from George Washington University and a graduate degree from Fordham University School of Law.


Posti e reponsabilitÓ di David M. Tanen 
NomeTitolo Da
Kronos Bio, Inc.
(Biotecnologia)
Director -
Allogene Therapeutics, Inc.
(Biotecnologia)
Secretary -
Riverbank Capital Securities, Inc. Director & Senior Managing Director 2013
Danube Pharmaceuticals, Inc. Director 1996
Two River Group Management LLC Director, Vice President & Managing Member -
Neogene Therapeutics, Inc. Secretary & Director 2018
Kirax Corp. Co-Founder 2005
Two Rivers Consulting Corp. Managing Member -
Two River Consulting LLC Partner -
Two River Group Holdings LLC Co-Founder & Partner 2011


Participazioni di David M. Tanen 
NomeAzioni%Valorizzazione
Kronos Bio, Inc. (KRON)
(Biotecnologia)
913 7631,62%19 106 784 USD


David M. Tanen: network personale 
Le notizie pi¨ lette 
22/09WILLIAM ACKMAN: Il fondo Pershing Square di Ackman sale mentre Universal sale al debutto in borsa
MR
24/09CATHIE WOOD: Il giro di vite cinese sul bitcoin è un altro colpo per l'ARK ETF di Cathie Wood
MR
15/09BRAD SMITH: Microsoft annuncia il riacquisto di azioni fino a 60 miliardi di dollari e aumenta il dividendo
MR
14/09STEPHEN SCHERR: Goldman Sachs nomina Coleman come nuovo CFO, sostituendo Scherr
MR
24/09PHILIPPE DONNET: Generali, comitato nomine a maggioranza propone lista Cda con Donnet Ceo - fonti
RE
24/09ELON MUSK: Auto, con nuovi impianti semiconduttori carenza chip avrà vita breve - Musk (Tesla)
RE
24/09LUIGI GUBITOSI: Tim, offerta per polo nazionale cloud in arrivo a breve - Gubitosi
RE
22/09JOHN ELKANN: Stellantis, Torino è città chiave per produzione gruppo - Elkann
RE
15/09FRANCESCO GAETANO CALTAGIRONE: Generali, Caltagirone aumenta quota di ulteriore 0,11%, sale sopra 6%
RE
27/09LEONARDO DEL VECCHIO: Generali, Del Vecchio compra un altro 0,03% del capitale
RE
Pi¨ notizie


© 2021 People and Ownership :   
David M. Tanen : connessioni